Tag: FDA bioequivalence
Partial AUC: Advanced Bioequivalence Measurements Explained
Partial AUC is a precision pharmacokinetic tool used to assess bioequivalence in complex drug formulations where traditional metrics like total AUC and Cmax fall short. It focuses on drug exposure during critical early time windows to ensure therapeutic safety and effectiveness.
Continue Reading
